Document Detail

Effects of nCPAP therapy on cardiorespiratory outcomes in obstructive sleep apnea syndrome: compliance and technological advancements.
MedLine Citation:
PMID:  21348585     Owner:  NLM     Status:  In-Data-Review    
Obstructive sleep apnea syndrome (OSAS) is an independent and modifiable risk factor for cardiovascular diseases; however, the pathophysiological mechanisms underlying this association are not yet fully understood. Intermittent hypoxemia, one of the physiological markers of OSAS, is characterized by transient periods of oxygen desaturation followed by reoxygenation. The hypoxia-reoxygenation cycles are associated with oxidative stress that, in turn, triggers the activation of pathways that lead to cardiovascular damage. The results of several studies show that OSAS causes oxidative stress and that nasal continuous positive airway pressure therapy normalizes these biological abnormalities. In conclusion, treatment of OSAS with continuous positive airway pressure may lower cardiovascular risk by reducing sympathetic nerve activity, ambulatory blood pressure and arterial stiffness, and by increasing sensitivity of the arterial baroreflex. Newer modalities such as C-Flex and A-Flex also show promise as treatment options in the future. However, the evidence supporting the use of these alternative modalities remains scant, in particular with regards to long-term cardiovascular outcomes.
Domenico M Toraldo; Francesco De Nuccio; Giuseppe Nicolardi
Related Documents :
5212375 - Determination of yield pressures: a method for measuring anal sphincter competence.
9605785 - The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: ...
38335 - Correlations between variations of electrical field at the body surface and contraction...
940225 - Relationship between pharmacological activity and blood level of a new anticholinergic ...
3360255 - Motor activity of the gastric antrum, pylorus, and duodenum under fasted conditions and...
3190625 - A preliminary report on a new anti-g maneuver.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of respiratory medicine     Volume:  5     ISSN:  1747-6356     ISO Abbreviation:  Expert Rev Respir Med     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101278196     Medline TA:  Expert Rev Respir Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  41-7     Citation Subset:  IM    
'A.Galateo' Lung Disease Hospital, Regional Service Puglia, ASL Lecce, 73100 Lecce, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Shrinking lung syndrome: recognition, pathophysiology and therapeutic strategy.
Next Document:  Photodynamic therapy for malignant pleural mesothelioma: the future of treatment?